BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3016270)

  • 1. Analogues of 1,3-dipropyl-8-phenylxanthine: enhancement of selectivity at A1-adenosine receptors by aryl substituents.
    Daly JW; Padgett WL; Shamim MT
    J Med Chem; 1986 Aug; 29(8):1520-4. PubMed ID: 3016270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
    Daly JW; Padgett W; Shamim MT; Butts-Lamb P; Waters J
    J Med Chem; 1985 Apr; 28(4):487-92. PubMed ID: 2984420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoionic xanthine analogues: antagonists of adenosine receptors.
    Glennon RA; Tejani-Butt SM; Padgett W; Daly JW
    J Med Chem; 1984 Oct; 27(10):1364-7. PubMed ID: 6090665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
    Schwabe U; Ukena D; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):212-21. PubMed ID: 2997628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors.
    Shamim MT; Ukena D; Padgett WL; Hong O; Daly JW
    J Med Chem; 1988 Mar; 31(3):613-7. PubMed ID: 3346878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
    Daly JW; Padgett WL; Shamim MT
    J Med Chem; 1986 Jul; 29(7):1305-8. PubMed ID: 3806581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.
    Jacobson KA; Gallo-Rodriguez C; Melman N; Fischer B; Maillard M; van Bergen A; van Galen PJ; Karton Y
    J Med Chem; 1993 May; 36(10):1333-42. PubMed ID: 8496902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.
    Martinson EA; Johnson RA; Wells JN
    Mol Pharmacol; 1987 Mar; 31(3):247-52. PubMed ID: 3561384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A1-adenosine receptors.
    Jacobson KA; Kiriasis L; Barone S; Bradbury BJ; Kammula U; Campagne JM; Secunda S; Daly JW; Neumeyer JL; Pfleiderer W
    J Med Chem; 1989 Aug; 32(8):1873-9. PubMed ID: 2754711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
    Shamim MT; Ukena D; Padgett WL; Daly JW
    J Med Chem; 1989 Jun; 32(6):1231-7. PubMed ID: 2724296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionalized congeners of 1,3-dipropyl-8-phenylxanthine: potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells.
    Ukena D; Daly JW; Kirk KL; Jacobson KA
    Life Sci; 1986 Mar; 38(9):797-807. PubMed ID: 3005794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
    Shimada J; Suzuki F; Nonaka H; Ishii A
    J Med Chem; 1992 Mar; 35(5):924-30. PubMed ID: 1548682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes.
    Ukena D; Schudt C; Sybrecht GW
    Biochem Pharmacol; 1993 Feb; 45(4):847-51. PubMed ID: 7680859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.
    Ukena D; Jacobson KA; Padgett WL; Ayala C; Shamim MT; Kirk KL; Olsson RO; Daly JW
    FEBS Lett; 1986 Dec; 209(1):122-8. PubMed ID: 3803571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonists.
    Peet NP; Lentz NL; Dudley MW; Ogden AM; McCarty DR; Racke MM
    J Med Chem; 1993 Dec; 36(25):4015-20. PubMed ID: 8258823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selectivity of the action of 1,3-dipropyl-8-phenylxanthine on the purine receptors of the intestines].
    Gmiro VE; Komissarov IV; Serdiuk SE; Kharin NA
    Farmakol Toksikol; 1988; 51(4):60-2. PubMed ID: 3191974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors.
    Linden J; Patel A; Earl CQ; Craig RH; Daluge SM
    J Med Chem; 1988 Apr; 31(4):745-51. PubMed ID: 3351850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
    Franchetti P; Messini L; Cappellacci L; Grifantini M; Lucacchini A; Martini C; Senatore G
    J Med Chem; 1994 Sep; 37(18):2970-5. PubMed ID: 8071944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors.
    Jacobson KA; Barone S; Kammula U; Stiles GL
    J Med Chem; 1989 May; 32(5):1043-51. PubMed ID: 2709373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction.
    SebastiĆ£o AM; Ribeiro JA
    Br J Pharmacol; 1989 Jan; 96(1):211-9. PubMed ID: 2924073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.